Immunotherapy has been one of the most transformative treatments for cancer patients in recent decades, shifting the emphasis ...
ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today presented new data from the first clinical study in Alzheimer's disease ...
How has the combination of antibody-drug conjugate and checkpoint inhibitors revolutionized treatment for patients with metastatic urothelial cancer? The clinical results from several trials suggest ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
This session, from the 2025 IO360 Summit, focuses on different strategies to augment immune response in urothelial carcinoma, presented by Dr Jonathan Rosenberg, Memorial Sloan Kettering Cancer Center ...
A research team investigating the use of the bacterium Listeria monocytogenes against colorectal cancer has discovered a way to build a modified version of Listeria as an oral vaccine to prime the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results